The ACA’s Cost Sharing Reduction: Protecting Consumers From High Out Of Pocket Health Care Costs

This blog piece from Families USA discusses cost sharing under ACA and how it reduces out-of-pocket health care costs. Click here to download. 

Building on ACA’s success Will Help Millions With Substance Use Disorders

The Center on Budget and Policy Priorities (CBPP) presents a policy futures piece which provides suggestions for supporting substance users including Medicaid expansion, SUD coverage, maintaining financial structure, and avoiding barriers to coverage.  Click here to download and read. 

Building Health Literacy and Family Engagement in Head Start Communities : A Case Study

Bhavna Sivanand, MBA, MPH, [email protected] at UCLA Anderson School of Management, and Northrop Nonprofit Consulting; Ariella Herman, MS, PhD, UCLA/Johnson & Johnson Health Care Institute, Harold and Pauline Price Center for Entrepreneurship & Innovation, and UCLA Anderson School of Management; Carol Teutsch, MD, Health Care Institute; Steven Teutsch, MD, MPH, UCLA Fielding School of Public Health, Public Health Institute, and Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California. April 14, 2017

This discussion paper provides a case study to discuss how parent engagement improves health behaviors and health outcomes for mothers and head start children.  It talks about how improving family engagement and health literacy can improve health outcomes.  The paper is meant to direct future policy direction.  Click here to download. 

NAPSW Signs Onto Letter to American Academy of Pediatrics to Increase Access to RSV Prevention

NAPSW joins with the National Coalition for Infant Health (NCfIH), a group of more than 150 professional, clinical, community health, and family support organizations to advocate for increased access to RSV protection. NCfIH advocates for access to approved clinical therapies demonstrated to improve the lives of premature infants and their families. The coalition has particular concern about the lack of access to preventive treatment for Respiratory Syncytial Virus (RSV) faced by the majority of premature infants.  Over 70 percent of premature infants born between 30 and 35 weeks gestation, are beyond the cut-off gestational age in the AAP'S Committee on Infectious Diseases (COID) 2014 policy to receive Palivizumab (Synagis) administration, which has been proven to prevent and/or lessen the severity of RSV disease. However, these excluded premature infants born between 30 and 35 weeks gestation are vulnerable, with premature lungs and fragile immune systems that heighten their risk to contract RSV. Worse, these eligibility guidelines disproportionately affect African American and low-income families, whose babies are more likely to be born prematurely and suffer from other disparities. Click here to read the letter and learn more.